In recent years, the search for molecules that bind to the BH3 domain on Bcl-2 and Mcl-1 has been proposed, as it could be promising for the therapy of cancers and some types of NHL with the overexpression of these proteins [49]. This evidence concerns the gene BCL2 and non-Hodgkin lymphoma.